Cargando…
Enlarged adipocytes from subcutaneous vs. visceral adipose tissue differentially contribute to metabolic dysfunction and atherogenic risk of patients with obesity
Morphological characteristics and source of adipose tissue as well as adipokines may increase cardiometabolic risk. This study aimed to explore whether adipose tissue characteristics may impact metabolic and atherogenic risks. Subcutaneous Adipose Tissue (SAT), Visceral Adipose Tissue (VAT) and peri...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815822/ https://www.ncbi.nlm.nih.gov/pubmed/33469087 http://dx.doi.org/10.1038/s41598-021-81289-2 |
_version_ | 1783638314673242112 |
---|---|
author | Suárez-Cuenca, Juan Antonio De La Peña-Sosa, Gustavo De La Vega-Moreno, Karen Banderas-Lares, Diana Zaineff Salamanca-García, Moisés Martínez-Hernández, José Enrique Vera-Gómez, Eduardo Hernández-Patricio, Alejandro Zamora-Alemán, Carlos Ramiro Domínguez-Pérez, Gabriela Alexandra Ruíz-Hernández, Atzín Suá Gutiérrez-Buendía, Juan Ariel Melchor-López, Alberto Ortíz-Fernández, Moisés Montoya-Ramírez, Jesús Gaytán-Fuentes, Omar Felipe Toríz-Ortíz, Angélica Osorio-Valero, Mario Orozco-Vázquez, Julita Alcaráz-Estrada, Sofía Lizeth Rodríguez-Arellano, Martha Eunice Maldonado-Arriaga, Brenda Pérez-Cabeza de Vaca, Rebeca Escamilla-Tilch, Mónica Pineda-Juárez, Juan Antonio Téllez-González, Mario Antonio García, Silvia Mondragón-Terán, Paul |
author_facet | Suárez-Cuenca, Juan Antonio De La Peña-Sosa, Gustavo De La Vega-Moreno, Karen Banderas-Lares, Diana Zaineff Salamanca-García, Moisés Martínez-Hernández, José Enrique Vera-Gómez, Eduardo Hernández-Patricio, Alejandro Zamora-Alemán, Carlos Ramiro Domínguez-Pérez, Gabriela Alexandra Ruíz-Hernández, Atzín Suá Gutiérrez-Buendía, Juan Ariel Melchor-López, Alberto Ortíz-Fernández, Moisés Montoya-Ramírez, Jesús Gaytán-Fuentes, Omar Felipe Toríz-Ortíz, Angélica Osorio-Valero, Mario Orozco-Vázquez, Julita Alcaráz-Estrada, Sofía Lizeth Rodríguez-Arellano, Martha Eunice Maldonado-Arriaga, Brenda Pérez-Cabeza de Vaca, Rebeca Escamilla-Tilch, Mónica Pineda-Juárez, Juan Antonio Téllez-González, Mario Antonio García, Silvia Mondragón-Terán, Paul |
author_sort | Suárez-Cuenca, Juan Antonio |
collection | PubMed |
description | Morphological characteristics and source of adipose tissue as well as adipokines may increase cardiometabolic risk. This study aimed to explore whether adipose tissue characteristics may impact metabolic and atherogenic risks. Subcutaneous Adipose Tissue (SAT), Visceral Adipose Tissue (VAT) and peripheral blood were obtained from obese patients submitted to bariatric surgery. Adipose tissue (morphometry), plasma adiponectin, TNF-α, resistin (multiplexing) and biochemical chemistry were analyzed; as well as endothelial dysfunction (Flow Mediated Dilation, FMD) and atherogenesis (Carotid Intima Media Thickness, CIMT). Subgroups divided by adipocyte size and source were compared; as well as correlation and multivariate analysis. Sixty patients 36.6% males, aged 44 years-old, BMI 46.7 kg/m(2) were included. SAT’s adipocytes showed a lower range of size expandability than VAT’s adipocytes. Independent from their source, larger adipocytes were associated with higher glucose, lower adiponectin and higher CIMT. Particularly, larger adipocytes from SAT were associated with higher blood pressure, lower insulin and HDL-cholesterol; and showed positive correlation with glucose, Hb(A1c), systolic/diastolic values, and negatively correlated with insulin and adiponectin. VAT’s larger adipocytes particularly associated with lower resistin and lower FMD values. Gender and Diabetes Mellitus significantly impacted the relation of adipocyte size/source with the metabolic and atherogenic risk. Multivariable analysis suggested hypertension-resistin-Hb(A1c) interactions associated with SAT’s larger adipocytes; whereas potential insulin-adiponectin associations were observed for VAT’s larger adipocytes. Adipocyte morphology and source are differentially related with cardiometabolic and atherogenic risk in population with obesity, which are potentially affected by gender and Diabetes Mellitus. |
format | Online Article Text |
id | pubmed-7815822 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-78158222021-01-21 Enlarged adipocytes from subcutaneous vs. visceral adipose tissue differentially contribute to metabolic dysfunction and atherogenic risk of patients with obesity Suárez-Cuenca, Juan Antonio De La Peña-Sosa, Gustavo De La Vega-Moreno, Karen Banderas-Lares, Diana Zaineff Salamanca-García, Moisés Martínez-Hernández, José Enrique Vera-Gómez, Eduardo Hernández-Patricio, Alejandro Zamora-Alemán, Carlos Ramiro Domínguez-Pérez, Gabriela Alexandra Ruíz-Hernández, Atzín Suá Gutiérrez-Buendía, Juan Ariel Melchor-López, Alberto Ortíz-Fernández, Moisés Montoya-Ramírez, Jesús Gaytán-Fuentes, Omar Felipe Toríz-Ortíz, Angélica Osorio-Valero, Mario Orozco-Vázquez, Julita Alcaráz-Estrada, Sofía Lizeth Rodríguez-Arellano, Martha Eunice Maldonado-Arriaga, Brenda Pérez-Cabeza de Vaca, Rebeca Escamilla-Tilch, Mónica Pineda-Juárez, Juan Antonio Téllez-González, Mario Antonio García, Silvia Mondragón-Terán, Paul Sci Rep Article Morphological characteristics and source of adipose tissue as well as adipokines may increase cardiometabolic risk. This study aimed to explore whether adipose tissue characteristics may impact metabolic and atherogenic risks. Subcutaneous Adipose Tissue (SAT), Visceral Adipose Tissue (VAT) and peripheral blood were obtained from obese patients submitted to bariatric surgery. Adipose tissue (morphometry), plasma adiponectin, TNF-α, resistin (multiplexing) and biochemical chemistry were analyzed; as well as endothelial dysfunction (Flow Mediated Dilation, FMD) and atherogenesis (Carotid Intima Media Thickness, CIMT). Subgroups divided by adipocyte size and source were compared; as well as correlation and multivariate analysis. Sixty patients 36.6% males, aged 44 years-old, BMI 46.7 kg/m(2) were included. SAT’s adipocytes showed a lower range of size expandability than VAT’s adipocytes. Independent from their source, larger adipocytes were associated with higher glucose, lower adiponectin and higher CIMT. Particularly, larger adipocytes from SAT were associated with higher blood pressure, lower insulin and HDL-cholesterol; and showed positive correlation with glucose, Hb(A1c), systolic/diastolic values, and negatively correlated with insulin and adiponectin. VAT’s larger adipocytes particularly associated with lower resistin and lower FMD values. Gender and Diabetes Mellitus significantly impacted the relation of adipocyte size/source with the metabolic and atherogenic risk. Multivariable analysis suggested hypertension-resistin-Hb(A1c) interactions associated with SAT’s larger adipocytes; whereas potential insulin-adiponectin associations were observed for VAT’s larger adipocytes. Adipocyte morphology and source are differentially related with cardiometabolic and atherogenic risk in population with obesity, which are potentially affected by gender and Diabetes Mellitus. Nature Publishing Group UK 2021-01-19 /pmc/articles/PMC7815822/ /pubmed/33469087 http://dx.doi.org/10.1038/s41598-021-81289-2 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Suárez-Cuenca, Juan Antonio De La Peña-Sosa, Gustavo De La Vega-Moreno, Karen Banderas-Lares, Diana Zaineff Salamanca-García, Moisés Martínez-Hernández, José Enrique Vera-Gómez, Eduardo Hernández-Patricio, Alejandro Zamora-Alemán, Carlos Ramiro Domínguez-Pérez, Gabriela Alexandra Ruíz-Hernández, Atzín Suá Gutiérrez-Buendía, Juan Ariel Melchor-López, Alberto Ortíz-Fernández, Moisés Montoya-Ramírez, Jesús Gaytán-Fuentes, Omar Felipe Toríz-Ortíz, Angélica Osorio-Valero, Mario Orozco-Vázquez, Julita Alcaráz-Estrada, Sofía Lizeth Rodríguez-Arellano, Martha Eunice Maldonado-Arriaga, Brenda Pérez-Cabeza de Vaca, Rebeca Escamilla-Tilch, Mónica Pineda-Juárez, Juan Antonio Téllez-González, Mario Antonio García, Silvia Mondragón-Terán, Paul Enlarged adipocytes from subcutaneous vs. visceral adipose tissue differentially contribute to metabolic dysfunction and atherogenic risk of patients with obesity |
title | Enlarged adipocytes from subcutaneous vs. visceral adipose tissue differentially contribute to metabolic dysfunction and atherogenic risk of patients with obesity |
title_full | Enlarged adipocytes from subcutaneous vs. visceral adipose tissue differentially contribute to metabolic dysfunction and atherogenic risk of patients with obesity |
title_fullStr | Enlarged adipocytes from subcutaneous vs. visceral adipose tissue differentially contribute to metabolic dysfunction and atherogenic risk of patients with obesity |
title_full_unstemmed | Enlarged adipocytes from subcutaneous vs. visceral adipose tissue differentially contribute to metabolic dysfunction and atherogenic risk of patients with obesity |
title_short | Enlarged adipocytes from subcutaneous vs. visceral adipose tissue differentially contribute to metabolic dysfunction and atherogenic risk of patients with obesity |
title_sort | enlarged adipocytes from subcutaneous vs. visceral adipose tissue differentially contribute to metabolic dysfunction and atherogenic risk of patients with obesity |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815822/ https://www.ncbi.nlm.nih.gov/pubmed/33469087 http://dx.doi.org/10.1038/s41598-021-81289-2 |
work_keys_str_mv | AT suarezcuencajuanantonio enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity AT delapenasosagustavo enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity AT delavegamorenokaren enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity AT banderaslaresdianazaineff enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity AT salamancagarciamoises enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity AT martinezhernandezjoseenrique enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity AT veragomezeduardo enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity AT hernandezpatricioalejandro enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity AT zamoraalemancarlosramiro enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity AT dominguezperezgabrielaalexandra enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity AT ruizhernandezatzinsua enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity AT gutierrezbuendiajuanariel enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity AT melchorlopezalberto enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity AT ortizfernandezmoises enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity AT montoyaramirezjesus enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity AT gaytanfuentesomarfelipe enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity AT torizortizangelica enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity AT osoriovaleromario enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity AT orozcovazquezjulita enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity AT alcarazestradasofializeth enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity AT rodriguezarellanomarthaeunice enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity AT maldonadoarriagabrenda enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity AT perezcabezadevacarebeca enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity AT escamillatilchmonica enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity AT pinedajuarezjuanantonio enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity AT tellezgonzalezmarioantonio enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity AT garciasilvia enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity AT mondragonteranpaul enlargedadipocytesfromsubcutaneousvsvisceraladiposetissuedifferentiallycontributetometabolicdysfunctionandatherogenicriskofpatientswithobesity |